High materiality7/10
Camp4 Therapeutics price target lowered to $6 from $6.50 at Chardan
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Chardan maintains a target above current price with a modest cut to $6; current price around $3.85, suggesting upside potential remains.
- Target: $6
- Posted price: $3.85
- Firm: Chardan Capital
- Analyst: Keay Nakae
Key facts
- 01
Target: $6
- 02
Posted price: $3.85
- 03
Analyst firm: Chardan Capital
- 04
Analyst: Keay Nakae
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.